ArticleAMIA ... Annual Symposium proceedings. AMIA Symposium2016
Data Driven Approach to Burden of Treatment Measurement: A Study of Patients with Breast Cancer.
Article in AMIA ... Annual Symposium proceedings. AMIA Symposium, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- Temporary Stoppages and Burden of Treatment in Patients With Cancer.Oncology nursing forum · 2019Trial
- Economic impact of screening on postdiagnosis work productivity in Japanese women with breast cancer: a life-table modeling approach.Breast cancer (Tokyo, Japan) · 2025Article
- Characterization of time toxicity in older patients with metastatic breast cancer.Breast cancer research and treatment · 2024Article
- Estimating the Time Toxicity of Contemporary Systemic Treatment Regimens for Advanced Esophageal and Gastric Cancers.Cancers · 2023Article
- Low-intensity induction in acute myeloid leukemia. Always in the patients' best interest?Haematologica · 2023Article
- Evaluating telehealth for the education and monitoring of lymphoedema and shoulder dysfunction after breast cancer surgery.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2023Article
- Burden of Care for Patients With In-Transit Melanoma.The Journal of surgical research · 2023Article
- Using patient flow analysis with real-time patient tracking to optimize radiation oncology consultation visits.BMC health services research · 2022Article
- Patient satisfaction and cost analysis of telehealth delivered by allied health oncology clinicians.Contemporary oncology (Poznan, Poland) · 2022Article
- Opportunity Costs of Receiving Palliative Chemotherapy for Metastatic Pancreatic Ductal Adenocarcinoma.JCO oncology practice · 2020Article
- Characterizing communication patterns among members of the clinical care team to deliver breast cancer treatment.Journal of the American Medical Informatics Association : JAMIA · 2020Article
- Measures of Treatment Workload for Patients With Breast Cancer.JCO clinical cancer informatics · 2019Article
- Determining Burden of Commuting for Treatment Using Online Mapping Services - A Study of Breast Cancer Patients.AMIA ... Annual Symposium proceedings. AMIA Symposium · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chronic disease affects patient quality of life through symptoms of the disease and the work of receiving treatment. While the effects of illness are well investigated, the burden of treatment is not commonly studied or monitored. We developed a method to quantify one dimension of the burden of treatment based on patient encounters with the healthcare system. We applied this method to a population of stage I-III breast cancer patients. As hypothesized and observed, stage IIIpatients had more appointments, spent more time in clinic, and spent more time admitted to the hospital in the first 18 months after diagnosis compared to stage I and II patients. Future work will evaluate the reproducibility and generalizability of this method for quantifying burden of treatment across other clinical settings and chronic diseases. This approach could enable identification of high-risk groups that could benefit from interventions to decrease patient work and improve outcomes.
Indexed as
Identifiers
28269934PMC5333259What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.